Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

5.90USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,182
52-wk High
$7.05
52-wk Low
$3.35

Latest Key Developments (Source: Significant Developments)

Cytosorbents posts Q3 revenue of $3.8 mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cytosorbents Corp :Cytosorbents continues strong trajectory of growth in the third quarter 2017.Total Q3 2017 revenues increased 59% to $3.8 million​.  Full Article

CytoSorbents signs deal with Armaghan Salamat Kish Group to distribute CytoSorb in Iran
Friday, 23 Sep 2016 

CytoSorbents Corp :Has signed an exclusive distribution agreement with Armaghan Salamat Kish Group to distribute CytoSorb in Iran.  Full Article

Cytosorbents achieves fourth consecutive quarter of record Cytosorb sales
Tuesday, 9 Aug 2016 

Cytosorbents Corp : Cytosorbents achieves fourth consecutive quarter of record Cytosorb® sales . Qtrly loss per share $0.12 .Product sales for Q2 2016 were $1.9 million, an increase of approximately 140% over Q2 2015.  Full Article

Cytosorbents teams with Medial and Meditrade to bring CytoSorb to Hungary, Czech Republic, Slovakia, and Poland
Wednesday, 13 Jul 2016 

Cytosorbents Corp :Cytosorbents teams with medial and meditrade to bring Cytosorb to Hungary, Czech Republic, Slovakia, and Poland.  Full Article

CytoSorbents says independent monitoring board recommends continuation of REFRESH I trial
Friday, 27 May 2016 

CytoSorbents Corp : Independent data safety monitoring board recommends continuation of CytoSorbents REFRESH I trial . Independent data safety monitoring board found no safety concerns, recommended continuation of REFRESH I trial without changes .Plans to submit an investigational device exemption application later this year to initiate a pivotal, registration REFRESH 2 trial.  Full Article

Cytosorbents says total revenue for Q1 was $1.8 million
Monday, 9 May 2016 

Cytosorbents Corp : Says total revenue for Q1 of 2016 was $1.8 million, which includes both product sales and grant revenue .Says product gross margin for Q1 2016 was approximately 62% compared to approximately 59% for Q1 2015.  Full Article

BRIEF-Cytosorbents posts Q3 revenue of $3.8 mln

* Cytosorbents continues strong trajectory of growth in the third quarter 2017